Home  >>  Product Candidates  >>  Nasal Delivery of Pain Drugs

Nasal Delivery of Pain Drugs

Delivering medicines intranasally is a well-established, non-invasive and patient-friendly alternative to injections. There are a number of prescription medicines on the market today that use the nasal route of delivery to treat a range of conditions including allergic rhinitis, migraine and osteoporosis.

ROXRO's two lead compounds – Sprix™ for acute pain and ROX-828 for migraine – have been developed in a spray formulation for intranasal delivery. ROXRO believes that intranasal delivery has the potential to enhance these new products with several significant advantages. Among these benefits, ROXRO's intranasal medicines are:

Rapidly absorbed so they can begin working fast.

Can be better tolerated by patients who cannot take oral medicines or who experience nausea and vomiting.

A patient-friendly alternative to painful injections and invasive intravenous needles.

Avoids local effects in the gastrointestinal tract.

Delivered efficiently by avoiding first pass metabolism.